# Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

- Source: PR Newswire M&A
- Published: 2026-11-02T13:00:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/edgewise-therapeutics-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-302925830.html
- Canonical: https://groundlevelnews.com/story/edgewise-therapeutics-reports-inducement-grants-as-permitted-by-the-na-8cefe7/

BOULDER, Colo., Nov. 2, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. ("Edgewise" or the "Company"), (Nasdaq: EWTX), a leading clinical-stage cardiovascular biopharmaceutical company, today announced that on October 30, 2026, Edgewise granted inducement stock options to purchase a...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._